Raphael Pharmaceutical Inc. (RAPH): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$1.43M
As of 2025-12-31
-$1.89M
As of 2026-06-30
$128.0K2020-12-31: -$43.0K2021-12-31: $128.0K2022-12-31: $106.0K2023-12-31: $107.0K2024-12-31: -$742.0K2025-12-31: -$1.43M-$1.43M
2020-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$1.43Mn/m2026-03-31, Balance as of period end
2024-12-31-$742.0Kn/m2026-03-31, Balance as of period end
2023-12-31$107.0K+0.9%2025-03-31, Balance as of period end
2022-12-31$106.0K-17.2%2024-03-28, Balance as of period end
2021-12-31$128.0Kn/m2023-05-25, Balance as of period end
2020-12-31-$43.0Kn/a2022-03-30, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Raphael Pharmaceutical Inc. (RAPH)2025-12-31-$1.43Mn/m
China Foods Holdings Ltd. (CFOO)2025-12-31-$1.28Mn/m
Nutra Pharma Corp (NPHC)2025-12-31-$16.83Mn/m
Adia Nutrition, Inc. (ADIA)2025-12-31-$257.7Kn/m
Aibotics, Inc. (AIBT)2025-12-31-$3.96Mn/m
TFA Therapeutics, Inc. (RAJAF)2025-12-31-$534.6Kn/m
Regencell Bioscience Holdings Ltd (RGC)2025-06-30$4.86M-40.9%
Target Group Inc. (CBDY)2025-12-31-$8.06Mn/m
Functional Brands Inc. (MEHA)2025-12-31$1.54Mn/m

Compare RAPH, CFOO, NPHC, ADIA side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗